Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.41 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 10/20 | 0.40 |
| ▸ | PDE4A | P27815 | 2/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.40 |
| ▸ | CDC25A | P30304 | 1/20 | 0.39 |
| ▸ | CDC25B | P30305 | 1/20 | 0.39 |
| ▸ | PDE2A | O00408 | 1/20 | 0.38 |
| ▸ | PDE5A | O76074 | 1/20 | 0.38 |
| ▸ | PDE1A | P54750 | 1/20 | 0.38 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.38 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7796197 | 0.87 | PDE4A (0.44) | LTB4RHSP90AB1PDE4APDE4BPDE4C | |
| SCHEMBL7796288 | 0.81 | PDE5A (0.45) | PDE2APDE5AKDM4EALDH1A1 | |
| SCHEMBL7796184 | 0.80 | LTB4R (0.44) | LTB4RHSP90AB1CDC25ACDC25BKDM4E | |
| SCHEMBL149749 | 0.77 | PDE4A (0.57) | LTB4RHSP90AB1PDE4APDE4BPDE4C | |
| SCHEMBL7794732 | 0.77 | PDE4A (0.49) | LTB4RHSP90AB1PDE4APDE4BPDE4C | |
| SCHEMBL29801535 | 0.77 | LTB4R (0.43) | LTB4RHSP90AB1PDE4APDE4BPDE4C | |
| SCHEMBL7796503 | 0.77 | PDE4A (0.53) | LTB4RHSP90AB1PDE4APDE4BPDE4C | |
| Hydrochloric Acid SCHEMBL28844121 | 0.77 | PDE4A (0.57) | LTB4RHSP90AB1PDE4APDE4BPDE4C | |
| SCHEMBL27379808 | 0.76 | LTB4R (0.43) | CTSLLTB4RHSP90AB1PDE4APDE4B | |
| SCHEMBL2232147 | 0.76 | PDE5A (0.58) | LTB4RHSP90AB1PDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010031760-A1 | Method of treating a patient having precancerous lesions with quinazoline derivatives | PAMUKCU RIFAT (US) | 2001-10-18 | — | — | US | disclosed |
| US-5693652-A | Benzimidazoles for ischemic heart conditions | EISAI CO., LTD. (JP) | 1997-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031760-A1 | Method of treating a patient having precancerous lesions with quinazoline derivatives | MKI67, PCNA, NQO2 | CTSL 1068/4885LTB4R 1536/4885HSP90AB1 2725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.